Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-05-10 09:19 am Sale | 2023-04-30 | 13G | PMV Pharmaceuticals, Inc. PMVP | STATE STREET CORP STT | 646,550 1.410% | -2,660,686 (-80.45%) | Filing History |
| 2023-02-14 1:10 pm Purchase | 2022-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | Boxer Capital LLC | 3,163,795 6.900% | 325,559 (+11.47%) | Filing History |
| 2023-02-14 10:07 am Purchase | 2022-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | RTW Investments, LP | 4,356,920 9.500% | 1,375,960 (+46.16%) | Filing History |
| 2023-02-14 09:35 am Purchase | 2022-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | AVORO CAPITAL ADVISORS LLC | 3,060,000 6.700% | 1,595,000 (+108.87%) | Filing History |
| 2023-02-14 08:26 am Sale | 2022-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | Citadel Advisors LLC | 1,384,499 3.000% | -1,025,343 (-42.55%) | Filing History |
| 2023-02-10 1:00 pm Sale | 2010-02-28 | 13G | PMV Pharmaceuticals, Inc. PMVP | INTERWEST PARTNERS X LP | 1,714,540 3.800% | -1,535,004 (-47.24%) | Filing History |
| 2023-02-10 11:26 am Sale | 2022-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | STATE STREET CORP STT | 3,307,236 7.240% | -1,864,254 (-36.05%) | Filing History |
| 2023-02-09 11:30 am Purchase | 2022-12-30 | 13G | PMV Pharmaceuticals, Inc. PMVP | The Vanguard Group | 2,753,606 6.030% | 105,660 (+3.99%) | Filing History |
| 2023-01-31 1:58 pm Purchase | 2022-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | BlackRock Inc. BLK | 3,451,367 7.600% | 911,543 (+35.89%) | Filing History |
| 2023-01-25 12:18 pm Sale | 2022-12-30 | 13G | PMV Pharmaceuticals, Inc. PMVP | JPMORGAN CHASE & CO JPM | 4,004,767 8.700% | -580,692 (-12.66%) | Filing History |
| 2023-01-24 2:44 pm Sale | 2022-12-30 | 13G | PMV Pharmaceuticals, Inc. PMVP | Cowen Financial Products LLC | 1,500,326 3.280% | -799,674 (-34.77%) | Filing History |
| 2022-07-11 1:28 pm Purchase | 2022-06-30 | 13G | PMV Pharmaceuticals, Inc. PMVP | STATE STREET CORP STT | 5,171,490 11.350% | 5,171,490 (New Position) | Filing History |
| 2022-07-07 10:06 am Purchase | 2022-06-30 | 13G | PMV Pharmaceuticals, Inc. PMVP | JPMORGAN CHASE & CO JPM | 4,585,459 10.000% | 1,419,009 (+44.81%) | Filing History |
| 2022-06-17 4:02 pm Purchase | 2022-06-07 | 13G | PMV Pharmaceuticals, Inc. PMVP | Citadel Advisors LLC | 2,409,842 5.300% | 2,409,842 (New Position) | Filing History |
| 2022-04-01 5:06 pm Unchanged | 2022-03-29 | 13D | PMV Pharmaceuticals, Inc. PMVP | ORBIMED ADVISORS LLC | 6,589,330 14.500% | 0 (Unchanged) | Filing History |
| 2022-02-14 5:01 pm Sale | 2021-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | VIKING GLOBAL INVESTORS LP | 1,790,284 3.900% | -573,778 (-24.27%) | Filing History |
| 2022-02-14 4:16 pm Purchase | 2021-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | Boxer Capital LLC | 2,838,236 6.300% | 570,000 (+25.13%) | Filing History |
| 2022-02-14 4:00 pm Sale | 2021-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | Nextech V Oncology S.C.S. SICAV-SIF | 1,385,807 3.100% | -1,142,483 (-45.19%) | Filing History |
| 2022-02-14 08:39 am Purchase | 2021-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | RTW Investments, LP | 2,980,960 6.600% | 2,980,960 (New Position) | Filing History |
| 2022-02-14 07:17 am Sale | 2021-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | Euclidean Capital LLC | 2,336,909 5.100% | -118,290 (-4.82%) | Filing History |